UNITED STATES HYALURONIC ACID MARKET FORECAST 2025-2032

Upcoming opportunities lie in the increasing demand for hyaluronic acid supplements, particularly for joint health and skin hydration. As awareness grows regarding hyaluronic acid benefits in systemic wellness, players in the market are developing innovative oral and dietary products. Factors such as an aging population, increasing disposable income, and the popularity of holistic beauty trends are boosting the consumption of hyaluronic acid products across demographics.

The United States hyaluronic acid market segmentation includes grade, form, type, source, route of administration, and application. The form segment is further classified into linear hyaluronic acid and cross-linked hyaluronic acid.

The hyaluronic acid market in the United States is characterized by a strong preference for injectable and cross-linked hyaluronic acid. These types are widely used in aesthetic treatments, including hyaluronic acid fillers, which remain one of the most growing applications in the country. Over 3 million injectable treatments involving hyaluronic acid benefits are performed annually, driven by the demand for anti-aging products and the popularity of non-invasive procedures.

One of the fastest-growing applications is in dermal fillers, as consumers seek hyaluronic acid for skin that appears plump and hydrated. Hyaluronic acid injections offer a minimally invasive solution for volume loss and fine lines, appealing to younger populations adopting preventative treatments and older individuals desiring rejuvenation. The adoption of hyaluronan in ophthalmology and orthopedics also highlights its therapeutic versatility, addressing conditions like dry eye syndrome and osteoarthritis.

Factors boosting this growth include increased awareness about cosmetic & personal care products and innovations in delivery methods. For example, manufacturers are introducing hybrid formulations combining hyaluronic acid benefits with peptides or antioxidants for enhanced efficacy. Additionally, the rise of e-commerce and personalized skincare has enabled consumers to access high-quality hyaluronic acid products conveniently. Emerging trends such as sustainable production and plant-based hyaluronic acid further align with consumer values, ensuring the market’s sustained expansion.

The top companies operating in the United States hyaluronic acid market include Anika Therapeutics Inc, F. Hoffmann-La Roche Ltd, Galderma, Givaudan SA, HTL Biotechnology, Salix Pharmaceuticals and Sanofi, etc.

Salix Pharmaceuticals, headquartered in Bridgewater, New Jersey, is a leading specialty pharmaceutical company focusing on gastrointestinal health and surgical solutions. Serving markets across the United States, the company develops innovative products to address unmet medical needs. Among its portfolio is Deflux®, a gel made from hyaluronic acid and dextranomer microspheres, designed to treat vesicoureteral reflux (VUR). Salix’s commitment to quality ensures that its hyaluronic acid products deliver clinical efficacy. With a focus on advanced biotechnologies, Salix contributes to the evolution of hyaluronic acid uses in therapeutic applications.